Brand-to-generic levetiracetam switching: a 4-year prospective observational real-life study.
M TrimboliE RussoL MumoliG TripepiF FortunatoG MastroianniF AbateG De SarroAntonio GambardellaAngelo LabatePublished in: European journal of neurology (2018)
In our sample, brand-to-generic levetiracetam switching was effective and safe in both monotherapy and polytherapy regardless of the epilepsy syndrome.